HSSA

sovereign capabilities across the health security ecosystem. In collaboration with Biointelect, the HSSA team provided the Australian Antimicrobial Resistance Network (AAMRNet) with a report on national capability in research and development relevant to AMR in Australia, after an exhaustive audit. The HSSA team reviewed current technology within the Australian diagnostic landscape with the aim of creating a consortia of experts and industry specialists, focused on sovereign manufacture of a diagnostic targeting priority pathogens in the IndoPacific region.

In May, General Manager HSSA Dr Felicia Pradera presented at the CBRNe Conference in Lille, France, focussing on the evolution of the National Health Security Resilience Assessment (NHSRA). The NHSRA examines Australia’s capability and capacity for research, development, manufacturing, supply chain resilience, and distribution of key products across the six key national health security sectors that comprise HSSA. Outcomes from the NHSRA were collected during this reporting year, and results were transformed into a user-friendly online navigator for stakeholders to view data and trends.

HSSA is now working to conceptualise/create a system that will utilise various data science methodologies to enable detailed insights into health security sector capability, capacity, products and services to inform prevention, preparedness, response and recovery planning for future priority CBRN threats. With funding from MTPConnect, the first focus area for this project will be to conduct horizon scanning for sovereign capabilities related to the growing threat of AMR.